Estrogen-replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging

Neurology

Volumn 50, Issue 4, 1998, Pages 996-1002

  Baldereschi, M ^a   Di Carlo, A ^a   Lepore, V ^b   Bracco, L ^b   Maggi, S ^a   Grigoletto, F ^b   Scarlato, G ^b   Amaducci, L ^a  

^a CNR   (Italy)

^b CNR PF Invecchiamento ^*

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; ITALY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL;

EID: 0031899264     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.4.996     Document Type: Article

References (42)

1. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102-1109.
2. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-1037.
3. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol 1994;140: 256-261.
4. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517-1521.
5. Tang MX, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:429-432.
6. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996;156: 2213-2217.
7. Waring SC, Rocca WA, Petersen RC, Kokmen E. Postmenopausal estrogen replacement therapy and Alzheimer's disease: a population-based study in Rochester, Minnesota. Neurology 1997;48(suppl 2):A79. Abstract.
8. Brenner DE, Kukull WA, Stergachis A, et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 1994;140:262-267.
9. Graves AB, White E, Koepsell TD, et al. A case-control study of Alzheimer's disease. Ann Neurol 1990;28:766-774.
10. Mayeux R, Tang MX, Marder K, Cote LJ, Jacobs DM, Stern Y. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology 1997;48(suppl 2):A79. Abstract.
11. Woolley CS, McEwen BS. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992;12:2549-2554.
12. Gould E, Woolley CS, Frankfurt M, McEwen BS. Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 1990;10:1286-1291.
13. Birge SJ. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996; 44:865-870.
14. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J Biol Chem 1994;269:13065-13068.
15. Ohkura T, Teshima Y, Isse K, et al. Estrogen increases cerebral and cerebellar blood flows in postmenopausal women. Menopause 1995;2:13-18.
16. Maggi S, Zucchetto M, Grigoletto F, et al. The Italian Longitudinal Study on Aging (ILSA): design and methods. Aging (Milano) 1994;6:464-473.
17. Folstein MF, Folstein SE, Mc Hugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, revised (DSM-III-R). Washington, DC: American Psychiatric Association, 1987: 103-107.
19. Baldereschi M, Zucchetto M, Grigoletto F, et al. Sensitivity, specificity and predictivity of an Italian version of the Mini-Mental State Examination. Ital J Neurol Sci 1993;7(suppl 14):59. Abstract.
20. Roth M, Tym E, Mountjoy CQ, et al. CAMDEX: a standardised instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698-709.
21. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323-329.
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
24. World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10). Chapter V, categories F00-F99. Mental, behavioural and developmental disorders, clinical description and diagnostic guidelines. Geneva: World Health Organization, 1992.
25. Baldereschi M, Pracucci G, Manzari C, et al. Interrater agreement on the clinical diagnosis of dementia: The Italian Longitudinal Study on Aging (ILSA). Ital J Neurol Sci 1993;7(suppl 14):10. Abstract.
26. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-1057.
27. 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-1029.
28. Fleiss JL. Statistical methods for rates and proportions. New York: John Wiley & Sons, 1981.
29. Glantz SA. Statistica per discipline bio-mediche. Milan: McGraw-Hill Libri Italia Srl., 1988.
30. Armitage P. Statistica medica. Milan: Giangiacomo Feltrinelli Editore, 1985.
31. Norusis MJ. SPSS for Windows: base system user's guide and advanced statistics, release 6.0. Chicago: SPSS, 1993.
32. Jolleys JV, Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas 1996;23:47-53.
33. Bush TL, Cowan LD, Barrett-Connor E, et al. Estrogen use and all-cause mortality: preliminary results from the Lipid Research Clinics Program Follow-up Study. JAMA 1983;249: 903-906.
34. Evans DA, Smith LA, Scherr PA, Albert MS, Funkenstein HH, Hebert LE. Risk of death from Alzheimer's disease in a community population of older persons. Am J Epidemiol 1991; 134:403-412.
35. Liu IY, LaCroix AZ, White LR, Kittner SJ, Wolf PA. Cognitive impairment and mortality: a study of possible confounders. Am J Epidemiol 1990;132:136-143.
36. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 1994;51:896-900.
37. Lerner A, Cole R, Debanne S, et al. Immunological and endocrine conditions in an Alzheimer's disease case-control study. Neuroepidemiology 1995;14:307. Abstract.
38. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 1995;7:334-337.
39. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988;13:345-357.
40. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-495.
41. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269:2637-2641.
42. Szklo M, Cerhan J, Diaz-Roux AV, et al. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1996; 144:1048-1057.